BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 331469)

  • 1. [Activation of the complement system in different forms of glomerulonephritis].
    Wegmüller E; Frey B; Hodler J
    Schweiz Med Wochenschr; 1977 Jul; 107(29):1028-34. PubMed ID: 331469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
    Perrin LH; Lambert PH; Miescher PA
    J Clin Invest; 1975 Jul; 56(1):165-76. PubMed ID: 1141431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Complement and nephritic activity in membranoproliferative glomerulonephritis].
    Lévy M; Sich M; Habib R
    Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LXIV-LXXIV. PubMed ID: 539879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terminal complement complex in plasma from patients with systemic lupus erythematosus and other glomerular diseases.
    Horigome I; Seino J; Sudo K; Kinoshita Y; Saito T; Yoshinaga K
    Clin Exp Immunol; 1987 Nov; 70(2):417-24. PubMed ID: 3427827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The complement system].
    Lambert PH
    Schweiz Med Wochenschr; 1975 Sep; 105(37):1180-4. PubMed ID: 1215899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement deposition in glomerular diseases.
    di Belgiojoso GB; Tarantino A; Durante A; Guerra L
    Proc Eur Dial Transplant Assoc; 1975; 11():515-21. PubMed ID: 1105561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin and complement deposits in lupus glomerulonephritis.
    Méry JP; Morel-Maroger L; Boelaert J
    Proc Eur Dial Transplant Assoc; 1975; 11():506-11. PubMed ID: 1197274
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum and glomerular complement in 205 cases of glomerulonephritis.
    Durante A; Rovati C; di Belgiojoso GB; Minetti L
    Proc Eur Dial Transplant Assoc; 1976; 12():189-96. PubMed ID: 935112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
    Schena FP; Pertosa G; Stanziale P; Vox E; Pecoraro C; Andreucci VE
    Clin Nephrol; 1982 Nov; 18(5):240-6. PubMed ID: 7151338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of complement in human nephritis.
    Lambert PH; Perrin LH; Mahieu P; Nydegger UE; Miescher PA
    Adv Nephrol Necker Hosp; 1974; 4():79-90. PubMed ID: 4220001
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunofluorescence patterns in chronic membranoproliferative glomerulonephritis (MPGN).
    Belgiojoso GB; Tarantino A; Bazzi C; Colasanti G; Guerra L; Durante A
    Clin Nephrol; 1976 Jul; 6(1):303-10. PubMed ID: 782750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between the component and regulatory proteins of the classical pathway C3 convertase.
    Welch TR; Forristal J; Beischel L
    J Lab Clin Med; 1986 Jun; 107(6):529-33. PubMed ID: 3635565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Specific measurement of alternate pathway activation of complement in human glomerulonephritides (GN): 125 cases (author's transl)].
    Berthoux FC; Freyria AM
    Nephrologie; 1980; 1(2):61-6. PubMed ID: 7301022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clearances of complement components, C3 proactivator and other serum proteins in chronic membranoproliferative glomerulonephritis (CMPGN).
    Geiger H; Good RA; Day NK
    Clin Nephrol; 1975; 3(4):139-47. PubMed ID: 1149337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the properdin amplification loop in membranoproliferative and other forms of glomerulonephritis.
    Whaley K; Ward D; Ruddy S
    Clin Exp Immunol; 1979 Jan; 35(1):101-6. PubMed ID: 85507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properdin levels in systemic lupus erythematosus and membranoproleferative glomerulonephritis.
    Perrin LH; Lambert PH; Miescher PA
    Clin Exp Immunol; 1974 Apr; 16(4):575-81. PubMed ID: 4219766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for activation of the alternate pathway in glomerulonephritis.
    Michael AF; McLean RH
    Adv Nephrol Necker Hosp; 1974; 4():49-66. PubMed ID: 4219999
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies of serum complement in the hypocomplementaemic nephritides.
    Williams DG; Peters DK; Fallows J; Petrie A; Kourilsky O; Morel-Maroger L; Cameron JS
    Clin Exp Immunol; 1974 Nov; 18(3):391-405. PubMed ID: 4219908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biological role of the complement system and the clinical importance of complement measurements.
    Füst G
    Haematologia (Budap); 1978-1979; 12(1-4):85-106. PubMed ID: 395046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classical complement pathway activation in membranoproliferative glomerulonephritis.
    Ooi YM; Vallota EH; West CD
    Kidney Int; 1976 Jan; 9(1):46-53. PubMed ID: 781380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.